For decades, the cosmetics industry has promised transformation, but it has never mentioned at what cost.
Emerging science about the insidious harms of cosmetics calls for a critical reckoning of regulation across Canada
By: Kelli Wood · April 8, 2026
Chapter 01
Hiding in Plain Sight
Every morning, millions of Canadian women engage in beauty routines that have been strategically marketed to promote confidence, self-care, and social acceptance. For generations, beauty products have been positioned as instruments of personal transformation. That framing, combined with the enormous reach of the global beauty industry, has obscured a troubling reality, as a growing body of peer-reviewed scientific research indicates that daily use of cosmetics may pose significant risks to consumer health.
The average North American woman applies 114 chemical ingredients to her skin before leaving the house. Most could not name a single one. Fewer still know that these products are subject to some of the weakest consumer protection regulations of any category sold in Canada.
This is not an oversight. It is by design.
This project—The Rouge Story of Cosmetics—was built to serve as an industry counter-narrative and as a beacon of belief in science. We want to simplify information meaningfully, and give fellow Canadians tools to safely navigate a shaky regulatory environment.
We have no hidden agenda. Rouge has no interest in steering you toward an alternative ‘clean’ product with a secret sales goal or hiding meaningful health information behind a subscription fee or a paywall. We share scientific facts, not
a marketing story that stokes or preys on insecurity, or sells brand belief. We only believe in giving you what you need to make the best choices for yourself.
Chapter 02
Absorbing the Costs
Those who have received a diagnosis know that the health consequences of cosmetic ingredients do not announce themselves. Instead, they are part of a bigger, long term picture, and they quietly accumulate insidiously over years of daily use.
A growing body of peer-reviewed research has linked common cosmetic ingredients—phthalates, parabens, formaldehyde, volatile silicones, lead, and talc—to endocrine disruption, reproductive harm, impaired neurodevelopment, and cancer. Many of these chemicals are absorbed through the skin and cannot be fully cleared after each application with soap or make up remover. The concern is not theoretical. It is documented in leading public health journals and has shaped regulatory policy on both sides of the Atlantic. The risk is compounded by a gap that regulators have left unaddressed. Canadians routinely apply products from multiple brand manufacturers in a single morning, often layering concealers, foundations, serums, and fragrances whose combined chemical interactions have never undergone joint toxicological assessment. Safety evaluations are conducted on individual ingredients in isolation, leaving the cumulative effect of dozens of simultaneous chemical interactions in the body largely unstudied. And when regulators do act to ban a harmful substance, replacement compounds frequently share similar molecular structures—a pattern toxicologists call regrettable substitution. Whether such substitutions address the underlying risk, or simply perpetuate it under a different name, is a question that Canada’s regulatory framework has no mechanism for answering.
A staggering 90% of individuals use some form of personal care product daily, making effective ingredient regulation a serious public health concern.
Source: Frontiers in Public Health, August 2024
Chapter 03
A System Not Designed For Its User
A peer-reviewed study of 231 cosmetic products purchased in Canadian and American stores found that more than half contained PFAS—per- and polyfluoroalkyl substances known as forever chemicals for their extreme persistence in the human body and the environment. They have been linked to cancer, hormonal disruption, and immune system impairment. To make matters worse, the majority of the products that contained them carried no disclosure on the label.
Unlike pharmaceuticals, cosmetics in Canada requires no pre-market approval before reaching consumers. The legislation that governs their sale, The Food and Drugs Act, contains a single consumer protection: no person shall sell a cosmetic that may cause injury to the health of the user. The provision was written in 1952,
a year in which the concept of endocrine disruption had not yet entered scientific literature, and cumulative chemical exposure was not yet understood as a public health concern. More than seventy years of research have transformed what we know about the ingredients in everyday products, while the legal standard used to govern them has not.
In its current form, Canada’s Food and Drug Act imposes no requirement on cosmetic manufacturers to conduct an independent safety assessment before a product reaches shelves. Unlike pharmaceuticals, cosmetic products can enter the market for sale without a pre-market review of any kind. There is no prescribed method by which safety must be demonstrated, which means that manufacturers are permitted to set and verify their own standards. When a consumer is harmed, there is no obligation to report it, as cosmetics are excluded from mandatory incident reporting under the Consumer Product Safety Act. And there is no requirement to verify that what appears on a product’s label actually matches what is in it. The 2016 Auditor General report found that Health Canada was not regularly testing products for prohibited substances or heavy metals.
The result is a system that assumes that a product is safe until evidence of harm accumulates. This posture naturally places the burden of proof not on the manufacturer before sale, but on the consumers who absorb the consequences after it.
In Canada, the presence of a product on a retail shelf offers no assurance of its safety. Recalls are typically initiated only after a documented pattern of consumer complaints. That process can take months or years to complete, and receives little public communication in the interim. The United States prohibits 11 cosmetic ingredients outright. Canada restricted 573. The European Union prohibits or restricts over 1,700. The gap between those numbers is not a matter of regulatory complexity. It is the product of a regulatory philosophy that places the burden of proof on consumers rather than manufacturers, and has never been asked to change.
When Health Canada does update its list of restricted ingredients, the change is recorded quietly on Canada.ca—a government webpage that the vast majority of consumers will never visit. There is no public alert, no notification from retailers to consumers, and no communication on the platforms where Canadians actually discover, research, and purchase the products those restrictions are meant
to address.
Further complicating the issue are the ingredient names on Canadian product labels, written in INCI nomenclature, a Latin-based chemical naming system developed for manufacturers, not for the people applying those products to their skin. The names were not designed to be understood by consumers. They were designed to satisfy a regulatory requirement. That requirement, in practice, is treated as exactly that. Ingredient lists are routinely set in the smallest permissible type, positioned on the back or base of the product, and occupy the lowest level of the label’s visual hierarchy. The front of the product is reserved for the brand and its promise. The ingredients—the information a consumer would need to make an informed decision—are placed where the eye is least likely to go and rendered in a language that assumes a chemist, as opposed to its target consumer, which is young women.
This is not a design failure. It is a disclosure system that was never seriously intended to communicate to a consumer audience. Canada’s own government reached the same conclusion. In 2016, Canada’s Office of the Auditor General concluded that Health Canada could not fully assure Canadians that its oversight was protecting them from dangerous chemicals in cosmetics. The department was not regularly testing products for prohibited substances or heavy metals. When harmful products were identified on store shelves, it took an average of nine months to remove them. That report was issued nearly a decade ago and the structural gaps it identified have still not been resolved. The European Union has responded to rising concerns about harmful cosmetic ingredients by banning or restricting more than 2,500 substances since 2009. Its framework works in tandem with the evolving science. It is scheduled, independent and structural. Under the EU’s Cosmetics Regulation, if a chemical is classified as carcinogenic, DNA-damaging, or toxic for reproduction, a ban is automatically triggered. The list is updated on a rolling basis as science develops. Effective January 1, 2026, France became the first EU member state to go further still, banning the manufacture, import, and sale of cosmetics containing PFAS outright.
But Canada has not followed. In March 2025, the federal government announced it would begin the process of formally classifying PFAS as toxic substances, a step that bans nothing and merely starts a clock. Under its proposed three-phase regulatory approach, a restriction on PFAS in cosmetics is a “Phase 2 priority”. Consultations on that phase are not scheduled to begin until 2027, and millions of Canadians will unknowingly continue to use ingredients of concern as part of their daily beauty routine.
88% of products with high PFAS levels failed to disclose their presence on the label, exposing a critical gap in US and Canadian labelling laws.
Source: Environmental Science & Technology Letters, June 2021
Chapter 04
A World That No Longer Exists
Canada’s cosmetic regulatory system was already failing the consumer it was built for. That consumer was an informed adult in 1952, capable of making rational decisions while standing in a store, reading a label. She lived in a world where the internet didn’t even exist and the primary forms of social comparison were bounded by her neighbourhood, workplace, magazines and eventually, the TV. While that customer certainly still exists today, the in-store strategies designed to reach her have been eclipsed by content models and hyper-aggressive marketing funnels that target her from every direction. They pull her down an overwhelming path to purchase and leverage social comparison from thousands of ‘aspirational’ peers across the globe as a primary reason to buy. The beauty industry knew the future was digital. And in a social media landscape algorithmically engineered to exploit insecurity and addiction, peer influence and affiliate referral now matters far more than the product label ever did.
TikTok has become the most powerful beauty counter in the world today.
TikTok Shop sells a beauty product every two seconds. Health and beauty products accounted for nearly 80 percent of TikTok Shop’s American sales in 2024, totalling $1.34 billion, driven in large part by paid influencer content. According to research by Euromonitor International, TikTok drove a 22 percent rise in beauty product sales across social media platforms in a single year. The cosmetics industry is not struggling to reach young consumers. It is reaching them with considerable precision, at considerable scale and through channels that Canada’s regulatory communication infrastructure does not use and cannot match.
The consequences of that gap are now being documented by regulators in other countries. In March 2026, Italy’s competition authority became the first European regulatory body to open a formal investigation into a major cosmetics retailer over its marketing of adult skincare products to children. The authority opened proceedings against Sephora and Benefit Cosmetics, alleging unfair commercial practices linked to what it described as cosmeticorexia: a culturally reinforced, compulsive preoccupation with skincare among minors. The authority found that critical information, including warnings that products had not been tested on minors—had been omitted or presented in a misleading manner, and characterized the use of young micro-influencers to reach this audience as an insidious marketing strategy.
There is currently no mechanism in Canada to inform a 13-year-old that the products appearing in her social media feed were formulated for adult skin, that their ingredients are listed in a nomenclature she has no reasonable means of decoding, or that the influencer recommending them received payment to do so. The industry has proved itself exceptionally capable of reaching this audience. The evidence is clear, the system that Canada designed to protect her was built for a world that no longer exists.
Chapter 05
The Moment of Reckoning
The new restrictions, investigations, and legislation enacted by France, Italy, and the European Union are not the positions of regulatory outliers. They are the measured responses of democratic governments to a documented and growing body of public health evidence. Denmark, California, Minnesota, Maine, and New Zealand have all moved to ban or restrict PFAS in consumer cosmetics. Environmental groups have noted that safer alternatives already exist for half of the cosmetic products tested in Canada, meaning a ban could be enacted without significant disruption to the market. Canada has chosen otherwise.
PFAs represent only one part of the problem. Other chemicals of concern such as phthalates, parabens, formaldehyde, lead, and talc that have been banned by the European Chemicals Agency remain entirely outside Canada’s current regulatory response. A ‘consultation’ scheduled for 2027 is not protection available today. And the limits of Canada’s existing oversight are not theoretical.
Dr. Amy Rand, an assistant professor of environmental chemistry at Carleton University, tested 38 cosmetic and personal care products sold in Canada. She found something the regulatory framework had missed entirely. Some products contained PFAs at levels a thousand times higher than the country’s own proposed regulatory threshold, and among them were compounds Canada had already prohibited. Her findings are a precise description of how the system is actually functioning. It has set rules it cannot enforce and drawn lines it cannot even see.
What stands between Canadian consumers and meaningful protection is not the science. What stands between them is a regulatory process that is poorly designed, terribly communicated, and political that’s subject to the sustained lobbying pressure of an industry with over 500 billion reasons to resist change. The gap between what science knows and what Canadians are told is not an accident. It is the predictable consequence of a system that was never designed with the end user in mind.